United States · FDA National Drug Code directory

VOXZOGO 0.56mg

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
68135-119_6100caa6-4951-4773-b80c-6be0c04efd24
Product NDC
68135-119
Form
KIT
Composition / generic term
vosoritide
Labeler
BioMarin Pharmaceutical Inc.
Marketing category
NDA
Marketing start / end (source format)
20211119
Source listing expiry
20261231

Source-listed ingredients

Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 KIT in 1 CARTON (68135-119-66) * 10 VIAL, SINGLE-DOSE in 1 CARTON (68135-094-84) / .7 mL in 1 VIAL, SINGLE-DOSE * 10 INJECTION, SOLUTION in 1 CARTON (68135-102-43) · 68135-119-66

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →